AG真人官方

Cloudflare, Inc. (NYSE: NET) insiders have filed Form 144 to sell up to 400 Class A shares (estimated value 鈮� US$76.6 k) through Morgan Stanley beginning 25 Jul 2025. The proposed sale equals just 0.0001 % of the company鈥檚 310.6 m shares outstanding, indicating a negligible float impact.

The filing also lists recent Rule 10b5-1 plan executions: seven transactions between 20 May 鈥� 21 Jul 2025 by Center Court鈥搑elated entities and Thomas J. Seifert totaling 95,826 shares for US$17.16 m in gross proceeds. All shares to be sold were originally acquired via option exercises on 16 Dec 2020 and paid for in cash.

Because the activity is governed by pre-arranged trading plans and represents a small fraction of outstanding stock, the filing is operationally immaterial. However, ongoing insider disposals may influence sentiment among investors sensitive to executive selling patterns.

KeyCorp (KEY) filed a Form 144 indicating an insider intends to sell 17,000 common shares through Fidelity Brokerage Services on 24 Jul 2025. The stock came from four restricted-stock vesting events dated Feb 2022-Feb 2024 and carries an aggregate market value of $317,475.

The planned sale equals roughly 0.0016 % of KeyCorp鈥檚 1.096 billion shares outstanding, so it is financially immaterial to the company. No other sales were reported in the past three months, and the filer certifies no undisclosed material information. Investors may watch follow-up Form 4 filings to confirm execution and assess insider sentiment.

Schedule 13G/A Amendment 22 discloses that First Trust Portfolios L.P., First Trust Advisors L.P. and their parent, The Charger Corp., collectively hold 12,194,520 shares of FT Vest U.S. Equity Buffer ETF 鈥� November (CUSIP 33740F847) as of 30 Jun 2025. The position represents 64.52 % of the ETF鈥檚 outstanding units.

All three Illinois-based entities report shared voting and dispositive power over the entire stake; none is held with sole authority. The shares are largely owned by unit investment trusts (UITs) sponsored by First Trust Portfolios and portfolios advised by First Trust Advisors. The UIT trustee, not the reporting persons, votes the shares to mirror the broader shareholder base, although First Trust Portfolios may exercise discretion under Rule 12d1-4 agreements. Each filer disclaims beneficial ownership.

The certification states the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. A Joint Filing Agreement is included as Exhibit 99.1.

On 22 July 2025, KeyCorp filed an Form 8-K (Item 2.02) to announce that its second-quarter 2025 financial results are now available.

• Exhibit 99.1: press release covering results for the three- and six-month periods ended 30 June 2025.
• Exhibit 99.2: supplemental information package used during the earnings call and webcast.
• Exhibit 99.3: consolidated balance sheets and statements of income; this exhibit is filed (subject to Exchange Act Section 18) and may be incorporated by reference in Securities Act filings, whereas Exhibits 99.1-99.2 are merely furnished.

The filing contains no quantitative metrics; investors must review the exhibits or KeyCorp鈥檚 website for revenue, EPS, credit-quality data, or guidance. Common shares (KEY) and four preferred depositary share series remain listed on the NYSE. The 8-K satisfies disclosure obligations without triggering automatic incorporation of the press release or slide deck into other SEC documents.

Fathom Holdings Inc. (FTHM) 鈥� Form 144 filed 07/21/2025. Insider Joshua K. Harley intends to sell up to 50,000 common shares through Merrill Lynch on Nasdaq. At the stated aggregate market value of $66,500, the proposed sale equals roughly 0.18 % of the 27.78 million shares outstanding.

The filing also discloses that Harley has already sold 67,592 shares between 07/16-07/18/2025 for gross proceeds of $90,022.84. Including the planned transaction, July disposals could reach 117,592 shares, or about 0.42 % of shares outstanding. The shares being sold were acquired via a 09/11/2018 conversion of Series B shares to common stock; no cash payment was involved.

While the dollar amounts are modest, consecutive insider sales may weigh on sentiment and add marginal selling pressure. No new operational or financial data are provided in the notice.

Form 4 filing summary 鈥� KeyCorp (KEY), 07/01/2025: Director Barbara R. Snyder converted 35,955 deferred shares (transaction code M) into an equal number of common shares. The conversion increased her directly held common-share position to 71,632 shares. No open-market purchase or sale price was reported because the shares derive from KeyCorp鈥檚 Directors鈥� Deferred Share Sub-Plan, where each deferred share is economically equivalent to a common share. Following the transaction, Snyder still holds 177,901 deferred shares that remain subject to the plan. The filing also notes that direct ownership totals include roughly 175 common shares obtained through the June 2025 dividend-reinvestment program, and deferred-share holdings include about 2,765 dividend-equivalent units accrued during the same period. As there was no disposition of shares and the transaction merely settles a long-standing equity award, the impact on KeyCorp鈥檚 public float and insider sentiment is modest.

Dyadic International, Inc. (Nasdaq: DYAI) filed a Form 8-K on 2 July 2025 to disclose a branding update. In 30 days the company will begin operating under the business name 鈥淒yadic Applied BioSolutions.鈥� The filing clarifies that the legal corporate name remains 鈥淒yadic International, Inc.,鈥� the DYAI ticker is unchanged, and the company will continue to trade on the Nasdaq Stock Market. The disclosure is provided under Item 7.01 (Regulation FD) and is furnished鈥攏ot filed鈥攖hereby carrying no Section 18 liability and no direct impact on financial statements. No financial data, operational revisions, or strategic transactions are included; the report solely communicates the forthcoming DBA designation and furnishes the related press release as Exhibit 99.1.

The Form 4 filing reports that Chemours Company (CC) director Courtney Mather was awarded 2,292 deferred stock units (DSUs) on 30 June 2025. Each DSU equals one share of common stock and will be settled in the first month after the director leaves the board. The award is recorded at a reference price of $11.45 per unit. After the grant, Mather directly owns 2,292 derivative securities; no sales or additional purchases of common stock were disclosed. Apart from this routine director compensation grant, the filing contains no other material transactions or changes in ownership.

Form 4 filing overview: On 06/30/2025, MAIA Biotechnology, Inc. (ticker MAIA) granted director Cristian Luput a package of stock options under the company鈥檚 2021 Equity Incentive Plan.

• Options granted: 21,350 options to purchase common shares.
• Exercise price: $1.80 per share.
• Vesting schedule: 100% vested immediately on the grant date.
• Expiration: 06/30/2035 (10-year term).
• Post-transaction holdings: Luput now holds 21,350 derivative securities directly.

No non-derivative share transactions were reported, and the filing was made individually by the director. The grant represents routine equity compensation designed to align director incentives with shareholder value, but it modestly increases the company鈥檚 fully diluted share count.